In Estimating Overdiagnosis, Details Matter.

@article{Baker2016InEO,
  title={In Estimating Overdiagnosis, Details Matter.},
  author={Jay A. Baker},
  journal={Academic radiology},
  year={2016},
  volume={23 1},
  pages={115-6}
}
(12). Naturally, as screening is implemented in the general population in the United States, continued monitoring and analysis of the clinical data will determine whether the benefits outweigh the costs and risks, and can be used to arrive at better estimates of overdiagnosis and to further refine the strategies for diagnosis and management of screen-detected nodules, to achieve maximal societal benefit at minimum costs and harms.